Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

BACKGROUND: We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer. METHODS: We systematically reviewed adjuvant randomized trials for non-metastatic pancreatic cancer after curative resect...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Run-Cong, Zou, Xue-Bin, Yuan, Shu-Qiang, Chen, Ying-Bo, Chen, Shi, Chen, Yong-Ming, Chen, Guo-Ming, Chen, Xiao-Jiang, Luo, Tian-Qi, Li, Shu-Man, Duan, Jin-Ling, Wang, Yun, Li, Yuan-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227225/
https://www.ncbi.nlm.nih.gov/pubmed/32410591
http://dx.doi.org/10.1186/s12885-020-06910-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227225/
https://www.ncbi.nlm.nih.gov/pubmed/32410591
http://dx.doi.org/10.1186/s12885-020-06910-5

Ejemplares similares